| Previous Close | 82.62 |
| Open | 82.47 |
| Bid | 83.28 x 200 |
| Ask | 83.37 x 200 |
| Day's Range | 82.01 - 83.37 |
| 52 Week Range | 63.76 - 86.27 |
| Volume | 5,654,657 |
| Avg. Volume | 9,365,871 |
| Market Cap | 108.74B |
| Beta | 0.91 |
| PE Ratio (TTM) | 9.04 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.53%) |
| Ex-Dividend Date | 2017-09-14 |
| 1y Target Est | N/A |
- Motley Fool•2 days ago
Oddly, Juno Therapeutics Is Jumping 11.3% Today
Optimism that it can develop CAR-T cancer drugs that are better than its competitors' is trumping news that the company is diluting investors by selling more shares.
- Zacks•2 days ago
Gilead's (GILD) Epclusa Receives Label Expansion in Canada
Gilead Sciences Inc. (GILD) announced that Health Canada has approved a label update of hepatitis C virus drug, Epclusa.
- Motley Fool•2 days ago
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
The biotech has $36.6 billion on the books, but the money might not be sitting in the right account.
